Jyotsana Thakkar

Jyotsana Thakkar practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Jyotsana Thakkar's NPI, 1407120991, was assigned on February 29, 2012. Jyotsana Thakkar holds Texas license Q5935.

Jyotsana Thakkar's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Jyotsana Thakkar's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Jyotsana Thakkar is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Jyotsana Thakkar to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jyotsana Thakkar practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Jyotsana Thakkar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Jyotsana Thakkar is licensed in Texas.

CMS data shows 268 Medicare services from Jyotsana Thakkar across 6 procedure codes in 2024, for 137 Medicare patients. Medicare paid $20,242 for them.

CMS counts 137 Medicare patients who saw Jyotsana Thakkar in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 5.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jyotsana Thakkar's median patient age at 66, with 52% women.

In 2024, Jyotsana Thakkar wrote 229 Medicare Part D claims for 53 patients. 91% of them were for generic drugs. CMS names the drug for 151 of them, across 7 drugs with 11 or more claims each, at $17,599 in total drug cost. In 2023, CMS named 149 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Jyotsana Thakkar for performance year 2024, reported as part of a group. Jyotsana Thakkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jyotsana Thakkar as offering telehealth.

Dmand AI links 11 papers to Jyotsana Thakkar, published from 2015 to 2022. 2015 was the busiest year, with 2. The most frequent topics are COVID-19, Acute Kidney Injury and Hospital Mortality. Jyotsana Thakkar has published most often in Kidney360. Jyotsana Thakkar's most frequent co-authors are Peter V. Dicpinigaitis, MD, Ladan Golestaneh, MD and Michael S. Aboodi, MD.

CMS Open Payments shows 13 general payments to Jyotsana Thakkar from 3 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 75% of the total. Travere Therapeutics, Inc. paid the most, $5,721.